Pain management, including intrathecal pumps

Current Pain and Headache Reports

Volumn 9, Issue 4, 2005, Pages 243-248

  Smith, Thomas J ^a   Swainey, Craig ^a   Coyne, Patrick J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FENTANYL; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; NITROUS OXIDE; OMEGA CONOTOXIN MVIIA; OPIATE DERIVATIVE; OXYCODONE; PLACEBO; PROTEIN P53;

ACUPUNCTURE; ANALGESIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BLEEDING DISORDER; CANCER INHIBITION; CANCER PAIN; CANCER PATIENT; CLINICAL TRIAL; COHORT ANALYSIS; CONSTIPATION; DEPRESSION; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EXPOSURE; FATIGUE; FEVER; HEMATOMA; HUMAN; INFECTION; INFUSION PUMP; INJECTION PAIN; MEDICAL EXPERT; NAUSEA; NONHUMAN; PAIN ASSESSMENT; PATIENT CARE; PERSONALITY DISORDER; POPULATION RESEARCH; PRACTICE GUIDELINE; REVIEW; SCORING SYSTEM; SKIN BRUISING; SOMNOLENCE; TREATMENT FAILURE; TREATMENT OUTCOME; URTICARIA; VISUAL ANALOG SCALE; VOMITING;

EID: 24044503343     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-005-0031-6     Document Type: Review

References (37)

1. Cleeland CS, Gonin R, Hatfield AK, et al.: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994, 330:592-596.
2. Von Roenn JH, Cleeland CS, Gonin R, et al.: Physician attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993, 119:121-126.
3. SUPPORT principal investigators: A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995, 274:1591-1598.
4. Desbiens NA, Wu AW: Pain and suffering in seriously ill hospitalized patients. J Am Geriatr Soc 2000, 48:S183-S186.
5. Anderson KO, Mednoza TR, Valero V, et al.: Minority cancer patients and their providers. Cancer 2000, 88:1929-1938.
6. Cherny NI, Catane R: Attitudes of medical oncologist toward palliative care for patients with advanced and incurable cancer. Cancer 2003, 98:2502-2510.
7. DuPen S, DuPen A, Polossar N, et al.: Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial. J Clin Oncol 1999, 17:361-370.
8. Smith TJ, Staats PS, Deer T, et al.: Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002, 20:4040-4049.
9. Meuser T, Pietruck C, Radbruch L, et al.: Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001, 93:247-257.
10. Miaskowski C, Dodd MJ, West C, et al.: Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 2001, 19:4275-4279.
11. O'Mahony S, Coyle N, Payne R: Current management of opioid-related side effects. Oncology 2001, 15:61-82.
12. Staats PS: The pain-mortality link: unraveling the mysteries. In Progression in Pain Research and Management. Edited by Payne R, Patt RH, Hill CS. Seattle, WA: IASP Press; 1998:145-156.
13. Liebeskind JC: Pain can kill. Pain 1991, 44:3-4.
14. Lillemoe K, Cameron JL, Kaufman HS, et al.: Chemical splanchnicectomy in patients with unresectable pancreatic cancer: a prospective randomized trial. An Surg 1993, 217: 447-455.
15. Staats P, Hekmat H, Sauter P, Lillemoe K: The effects of alcohol celiac plexus block, pain, and mood on longevity in patients with unresectable pancreatic cancer: a double-blind, randomized, placebo-controlled study. Pain Med 2001, 2:28-34.
16. Gupta K, Kshirsagar S, Chang L, et al.: Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002, 62:4491-4498.
17. Tegeder I, Grosch S, Schmidtko A, et al.: G protein-independent G1 cellcycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 2003, 63:1846-1852.
18. Ernst G, Pfaffenzeller P: Effect on morphine and other opioids on immune function. Schmerz 1998, 12:3-187.
19. DeVulder J, Ghys L, Dhondt W, Rolly G: Spinal analgesia in terminal care: risk versus benefit. J Pain Symptom Manage 1994, 9:75-81.
20. Hassenbusch S, Pillay P, Magdinec M, et al.: Constant infusion of morphine for intractable cancer pain using an implanted pump. J Neurosurg 1990, 73:405-409.
21. Onofrio B, Yaksh T: Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 1990, 72:200-209.
22. Penn R, Paice J: Chronic intrathecal morphine for intractable pain. J Neurosurg 1987, 67:182-186.
23. Gestin Y, Vainio A, Pegurier AM: Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer. Acta Anaesthesiol Scand 1997, 41:12-17.
24. Serlin RC, Mendoza TR, Nakamura Y, et al.: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995, 61:277-284.
25. Rauck RL, Cherry D, Boyer MF, et al.: Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain 2003, 4:441-447.
26. Staats PS, Yearwood T, Charapata SG, et al.: Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004, 291:63-70.
27. Hogan Q, Haddox JD, Abran S, et al.: Epidural opiates and local anesthetics for the management of cancer pain. Pain 1991, 46:271-279.
28. Smitt PS, Tsafka A, Teng-van de Zande F, et al.: Outcome and complications of epidural analgesia in patients with chronic cancer pain. Cancer 1998, 83:2015-2022.
29. Nitescu P, Dahm P, Appelgren L, Curelaru I: Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of 'refractory' nonmalignant pain. Clin J Pain 1998, 14:17-28.
30. Bruera E, Palmer JL, Bosnjak S, et al.: Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol 2004, 22:185-192.
31. Lauretti GR, Oliveira GM, Pereira NL: Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 2003, 89:2027-2030.
32. van Seventer R, Smit JM, Schipper RM, et al.: Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr Med Res Opin 2003, 19:457-469.
33. Harris JT, Suresh Kumar K, Rajagopal MR: Intravenous morphine for rapid control of severe cancer pain. Palliat Med 2003, 17:248-256.
34. Alimi D, Rubino C, Pichard-leandri E, et al.: Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003, 21:4120-4126.
35. Cerchietti LC, Navigante AH, Korte MW, et al.: Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 2003, 105:265-273.
36. Center to Advance Palliative Care. http://www.capc.org Accessed April 28, 2004.
37. Smith TJ, Coyne P, Staats P: What is the evidence for implantable drug delivery systems for refractory cancer pain? Support Cancer Ther 2004, in press.